2.0
10. Feb. 2024
Ehemaliger Mitarbeiter, mehr als 1 Jahr
Basel
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
- large company with ability to get to know lots of departments - however although you can do this - getting things moving with the above is difficult!
Kontras
- large, slow moving organisation - drug development seems to be left with poor quality leadership as many good people have left a while ago.